 |
Increasing your chances for success in First-In-Man studies |
Event Date: October 03, 2012 at 11:00 AM EDT |
The path to First in Man studies is a long road with many choices to make based on little to no information. In many cases, knowing the right path to take is dependent upon the signs read along the way and understanding which signs contain relevant information. Whether you are faced with bioavailability issues, financial constraints, or pressure to meet accelerated deadlines, having a well-designed development plan for your molecule can make the difference between success and failure.
This webcast will provide you with insight into how to find the right signs and understand them to help you speed along the path to achieve the best outcomes. You will hear a detailed case study about the development of an insoluble compound that otherwise never would have made it to First in Man and lessons learned from that experience. These presentations and interactive Q&A sessions will provide you with insight into how to speed your molecule to First in Man studies with an optimal formulation strategy.
Jason Vaughn will present information on "Successful Dosage Form Development for First in Man," and Jim Wright will speak on "A Case Study on Getting an Insoluble Compound into Man."
|
Moderator:
Angie Drakulich
Speakers:
Jason Vaughn, Ph.D.
Director of Scientific Affairs
Patheon, Inc
Jim Wright, Ph.D.
Chief Scientific Officer
BIND Biosciences
|
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Kristen Farrell, kfarrell@advanstar.com.
Register for this FREE Webcast!
|
 |
|